Latest Diabetes: Type II news
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes
posted July 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Resistance Training Tied to Lower Type 2 Diabetes Risk
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Time-Restricted Eating May Help Patients With Type 1 Diabetes 
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity 
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults Monthly Specialist Briefings
Stay Connected
